Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

recombinant human thrombopoietin

A recombinantly produced form of human thrombopoietin (rHuTPO). rHuTPO stimulates platelet formation and has potential use as a therapeutic agent to prevent thrombocytopenia in patients receiving chemotherapy.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:megakaryocyte growth and development factor
recombinant human TPO
Abbreviation:rhTPO
rHuTPO
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search